At least 5 stable disease patients from July who received an additional 4 months of treatment. Will be very interesting to see what happened to them.
I keep coming back to that TNBC case in the Phase I - dosed twice a week at 144mg/m2
After 2 cycles, demonstrated stable disease per RECIST;
After 4 cycles demonstrated 31% reduction in target lesion size (partial response)
Our stable disease patients will have received at least 6 cycles by end of October and would have been scanned again at 18 weeks (after cycle 4) and 24 weeks (after cycle 6)
Just a fun thought. If all the stable disease patients became partial responders with treatment that would mean that 9 out of the 15 patients with ORs or a 60% response rate among the original 15 patients. If this happens will all hell break loose? Will we see the greatest short squeeze of all time? Will anyone sell a share below $15?
Haha, maybe half at $10. We may be on the cusp of something very special here and like with KERX before their big news last year we are flying under the radar. Good things happen when you fly under the radar into a major event.
Shortnstock, WaitingforKerx, Kerx4Sale... drinks are on me if I'm right.
If you are right...I'll take a drink. I have that same enthusiasm in me....and hope that results are spectacular. I bet that the results will be spectacular and that the board pulled off the huge inside buy/company funding for a good reason. I doubt that they would have bought in such a big way without expecting great results and with upcoming presentations at SABCS putting the company in the spotlight. They had to know that SABCS would highlight trial successes and kick the stock price up much higher.
Just a couple of more days and as you say....all hell could break loose. Good luck....I can't wait for the end of the week to get here!!